Apoptosis(凋亡)
As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.
Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.
Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.
Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.
Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.
Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.
One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.
p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9).
Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.
References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.
Products for Apoptosis
- Caspase(99)
- 14.3.3 Proteins(1)
- Apoptosis Inducers(43)
- Bax(7)
- Bcl-2 Family(120)
- Bcl-xL(8)
- c-RET(9)
- IAP(27)
- KEAP1-Nrf2(66)
- MDM2(12)
- p53(123)
- PC-PLC(4)
- PKD(7)
- RasGAP (Ras- P21)(1)
- Survivin(8)
- Thymidylate Synthase(10)
- TNF-α(145)
- Other Apoptosis(883)
- APC(6)
- PD-1/PD-L1 interaction(90)
- ASK1(3)
- PAR4(2)
- RIP kinase(52)
- FKBP(20)
- Pyroptosis(31)
- Cat.No. 产品名称 Information
-
GC10744
Bendamustine HCl
盐酸苯达莫司汀; SDX-105
A DNA alkylating agent -
GC11511
Vincristine sulfate
硫酸长春新碱; Leurocristine sulfate; NSC-67574 sulfate; 22-Oxovincaleukoblastine sulfate
An antimitotic inhibitor of tubulin polymerization
-
GC12838
Edaravone
依达拉奉; MCI-186
A free radical scavenger -
GC15344
SP 600125
吡唑蒽酮
SP 600125是一种具有口服活性的、可逆的、具有选择性的ATP竞争性JNK 抑制剂,对JNK1、JNK2和JNK3的IC50分别为40、40和90nM。SP 600125常用于卵巢癌、肿瘤、帕金森病 (PD)、乳腺癌和哮喘的研究。 -
GC17621
TPCA-1
5-(4-氟苯基)-2-脲基噻吩-3-甲酰胺
A selective inhibitor of IKK2 -
GC17943
PD173074
PD 173074,PD-173074
PD173074是一种ATP竞争性FGFR1和VEGFR2抑制剂,IC50值分别为26nM和100-200nM,对FGFR1的选择性高于PDGFR和c-Src。 -
GC16694
TAE684 (NVP-TAE684)
TAE 684
A selective ALK inhibitor -
GC15485
LY 294002
LY294002/PI3K抑制剂
LY294002是第一个合成的PI3Kα、δ和β抑制剂。
-
GC16499
Sorafenib Tosylate
甲苯磺酸索拉非尼; Bay 43-9006 Tosylate
A multi-kinase inhibitor -
GC17198
Cycloheximide
Naramycin A; Actidione; 3-[2-(3,5-Dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]glutarimide
环己酰亚胺是一种抗生素,它在翻译水平上抑制蛋白质合成,仅对真核细胞的细胞质(80s)核糖体起作用。 -
GC17030
AZD6244(Selumetinib)
司美替尼; AZD6244; ARRY-142886
A highly selective inhibitor of MEK1/2 -
GC13028
SB 415286
3-[(3-氯-4-羟苯基)氨基]-4-(2-硝苯基)-1H-吡咯-2,5-二酮
A selective inhibitor of GSK-3 -
GC17990
PP 1
蛋白磷酸酯酶-1(抗原),AGL 1872; EI 275
Potent, selective Src family tyrosine kinase inhibitor -
GC12725
VX-765
Belnacasan; N-(4-氨基-3-氯苯甲酰基)-3-甲基-L-缬氨酰-N-[(2R,3S)-2-乙氧基四氢-5-氧代-3-呋喃基]-L-脯氨酰胺; VX-765
VX-765 是一种新开发的选择性小分子 caspase-1 抑制剂,可通过血脑屏障并在体外和体内减少炎症。
-
GC10111
Regorafenib
瑞戈非尼; BAY 73-4506
Regorafenib是一种具口服活性的多激酶抑制剂,抑制VEGFR1/2/3,PDGFRβ,Kit,RET和Raf-1的IC50值分别为13/4.2/46,22,7,1.5和2.5nM。 -
GC13163
Embelin
恩贝酸; Embelic acid; Emberine; NSC 91874
A benzoquinone with diverse biological activities -
GC15718
CID 2011756
An inhibitor of protein kinase D
-
GC10816
GDC-0941
GDC-0941
A pan inhibitor of class I PI3K isoforms -
GC16893
ICG 001
ICG001 是一种靶向 Wnt/β-catenin 通路的小分子抑制剂。
-
GC12450
BI 2536
BI-2536;BI2536
A potent inhibitor of Plk1 -
GC11247
PRIMA-1MET
APR-246
A re-activator of the apoptotic function of mutant p53 proteins -
GC11065
Pifithrin-μ
NSC 303580
Inhibitor of p53-mediated apoptosis -
GC10896
Cyclic Pifithrin-α hydrobromide
环状抑制剂-Α氢溴酸盐,Pifithrin-β
A stable inhibitor of p53 -
GC15503
NSC 687852 (b-AP15)
b-AP15
An inhibitor of the deubiquitinases USP14 and UCHL5 -
GC12353
Mitomycin C
丝裂霉素 C,Ametycine
Mitomycin C是一种抗生素,从链霉菌(Streptomyces Caespitosus)或淡紫色链霉菌(Streptomyces Lavendulae)中分离出来。 -
GC14321
Sal 003
(2E)-3-苯基-N-[2,2,2-三氯-1-[[[(4-氯苯基)氨基]硫代甲酰基]氨基]乙基]-2-丙烯酰胺
An inhibitor of eIF2α dephosphorylation -
GC12604
Fumonisin B1
伏马菌素B1
A mycotoxin
-
GC12660
AZD1208
AZD 1208;AZD-1208
AZD1208 是一种有效、高选择性且可口服的 Pim 激酶抑制剂,对 PIM1、PIM2 和 PIM3 的 IC50 值分别为 0.4、5 和 1.9nM。 -
GC11557
WR 1065
硫代乙基氨基乙基胺盐酸盐
A radioprotective agent -
GC13590
SJ 172550
MDMX Inhibitor II
A small molecule inhibitor of MDMX -
GC10589
RETRA hydrochloride
Antitumor agent
-
GC12086
PRIMA-1
NSC-281668
A re-activator of the apoptotic function of mutant p53 proteins -
GC12658
PhiKan 083
PhiKan 083 是一种咔唑衍生物,可与表面腔结合并稳定 Y220C(一种 p53 突变体),Kd 为 167 μM。 PhiKan 083 可用于癌症研究。
-
GC15621
NSC 146109 hydrochloride
XI-011
An activator of p53 -
GC12893
MIRA-1
NSC 19630
A mutant p53 reactivator -
GC10650
HLI 373
HLI 373 是一种有效的 Hdm2 抑制剂。
-
GC15840
CP 31398 dihydrochloride
A p53 stabilizing agent
-
GC11496
TLQP 21
TLQP 21 是一种 VGF 衍生肽,具有内分泌和内分泌特性,是一种有效的 G 蛋白偶联受体补体 3a 受体 1 (C3aR1) 激动剂(EC50:小鼠 TLQP 21\u003d10.3 μM;人 TLQP 21\u003d68.8 μM) .
-
GC17577
NQDI 1
A selective inhibitor of ASK1
-
GC12393
Melphalan
Alanine Nitrogen Mustard, Alkeran, NSC 8806, NSC 241286, L-Phenylalanine Mustard
DNA alkylating agent
-
GC10200
Mdivi 1
3-(2,4-二氯-5-甲氧基苯基)-2,3-二氢-2-硫代-4(1H)-喹唑啉酮,Mitochondrial division inhibitor 1
Mdivi-1(线粒体分裂抑制剂 1)抑制创伤性脑损伤 (TBI) 诱导的动力蛋白相关蛋白 1 (Drp1) 上调、自噬功能障碍和线粒体自噬激活。 -
GC15865
GRI 977143
An LPA2 receptor agonist
-
GC17650
DAPK Substrate Peptide
A DAPK1 peptide substrate
-
GC11543
Cesium chloride
氯化铯
氯化铯是钾通道的阻滞剂。 -
GC15571
SU 9516
A pro-apoptotic Cdk2/cyclin A inhibitor
-
GC16938
Muristerone A
米乐甾酮A
An ecdysteroid receptor agonist -
GC15400
MIM1
4-[[[2-(环己基亚氨基)-4-甲基-3(2H)-噻唑基]亚氨基]甲基]-1,2,3-苯三醇,Inhibitor of Mcl-1
An Mcl-1 inhibiting molecule -
GC12046
iMAC2
iMAC2 是一种有效的 MAC 抑制剂,IC50 为 28 nM,LD50 为 15000 nM。
-
GC15987
BIM, Biotinylated
Bim peptide fragment with a biotin moiety attached
-
GC16695
Bax inhibitor peptide, negative control
Peptide inhibit Bax translocation to mitochondria